18F-labeled difluoroestradiols: preparation and preclinical evaluation as estrogen receptor-binding radiopharmaceuticals
A-ring fluorination of estradiol (ES) at position 2 or 4 decreases the rate of metabolism by blocking the formation of catechol estrogens, one of the major metabolic pathways of ES. We postulate that adding a 2- or 4-fluoro substituent to 16α-[ 18 F ]fluoroestradiol (FES), a positron emission tomogr...
Gespeichert in:
Veröffentlicht in: | Steroids 2002-08, Vol.67 (9), p.765-775 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | A-ring fluorination of estradiol (ES) at position 2 or 4 decreases the rate of metabolism by blocking the formation of catechol estrogens, one of the major metabolic pathways of ES. We postulate that adding a 2- or 4-fluoro substituent to 16α-[
18
F
]fluoroestradiol (FES), a positron emission tomography (PET) radiopharmaceutical used for estrogen receptor (ER) imaging, should prolong its blood circulation time, and thus, improve its localization in ER-rich target tissues. On such account, we prepared a series of FES derivatives substituted with a fluorine atom at C2 or C4, with or without an 11β-OMe group, and we tested their binding affinities for the ER and different serum proteins including rat alphafetoprotein (AFP) and human sex hormone-binding globulin (SHBG). Labeling at the 16α-position was accomplished via nucleophilic substitution with [
18
F
]F
− on the reactive 16β,17β-cyclic sulfate intermediates. Decay corrected yields varied between 30 and 50% for a total synthesis time of 120
min, providing final products with specific activities >3000
Ci/mmol. The
18
F
-labeled analogs were evaluated for their biodistribution in immature female rats. Substitutions with the 4-F have little effect on binding affinities. Addition of the 2-F diminishes ER and AFP-binding affinities while augmenting the affinity for the SHBG. Addition of the 11β-OMe decreases all binding affinities, particularly to AFP and SHBG. In contrast, biodistribution of the corresponding [16α-
18
F
]fluoro analogs in immature female rats revealed that the presence of the 11β-OMe group improves ER-mediated uterus uptake, with the 4,16α-[16α-
18
F
]difluoro-11β-methoxyestradiol showing the highest uptake values (15% ID at 1-h post-injection). These data suggest that the addition of both a 4-F and 11β-OMe group onto FES may provide an improved radiopharmaceutical for PET imaging of ER densities in breast cancer patients. |
---|---|
ISSN: | 0039-128X 1878-5867 |
DOI: | 10.1016/S0039-128X(02)00025-9 |